Crossject SA announced the appointment of the experienced life sciences executive and medical affairs and clinical research specialist Dan Chiche, MD as Chief Medical Officer North America. Dr. Chiche has had a successful 20-year career history as an executive with top-tier pharmaceuticals companies such as Glaxo and Bristol Myers Squibb and has been involved in multiple projects for several biotech companies. He participated in key clinical developments of compounds in several therapeutic areas, including infectious diseases, HIV, hepatitis, influenza, oncology, rheumatoid arthritis, hypertension, diabetes, COPD and asthma.

Dr. Chiche has been CEO and CMO of Kompas Medical Services, since 2006, and in which he will continue to hold executive functions. He started his career at Glaxo and served in senior roles at Bristol Myers Squibb, and also worked as CMO of several relevant biotech companies such as Cytovia, Acasti and 35Pharma. He holds an MD from Paris-Saclay University with additional training in biostatistics and business administration.

Dr. Chiche is experienced in intensive care and emergency medicine and has intensive training in pre-hospital management of emergencies, as a former physician within the Paris fire department.